Albemarle Corp buy BMO Capital Markets
Start price
07.11.23
/
50%
€114.90
Target price
07.11.24
€168.34
Performance (%)
-19.53%
End price
08.11.24
€92.46
Summary
This prediction ended on 08.11.24 with a price of €92.46. The price of Albemarle Corp has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.53%. BMO_Capital_Markets has a follow-up prediction for Albemarle Corp where he still thinks Albemarle Corp is a Buy. Dividends of €1.47 are taken into consideration when calculating the performance. BMO_Capital_Markets has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Albemarle Corp | -0.265% | -0.265% | 83.065% |
| iShares Core DAX® | -1.596% | 1.524% | 3.017% |
| iShares Nasdaq 100 | 1.432% | 1.156% | 32.579% |
| iShares Nikkei 225® | 1.108% | 1.735% | 60.582% |
| iShares S&P 500 | 0.528% | 2.967% | 24.136% |
Comments by BMO_Capital_Markets for this prediction
In the thread Albemarle Corp diskutieren
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at BMO Capital Markets from $265.00 to $180.00. They now have an "outperform" rating on the stock.
Ratings data for ALB provided by MarketBeat
In the thread Trading Albemarle Corp
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten